State Ledger
Company profile

Aardvark Therapeutics, Inc. CIK 1774857

Ticker
AARD (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92122
Fiscal year end
2025 (FY)
Market Data
Close
$4.49
Change
-$0.26
Change %
-5.38%
Volume
2,217

AARD · trading date Oct 12, 2026 · previous close $4.74 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$57.59M
Total assets
$117.18M
Total liabilities
$10.55M
Stockholders' equity
$106.63M
Cash & equivalents
$47.05M
Operating income
-$62.73M
Operating cash flow
-$54.17M
Capital expenditures
$95.0K

Fiscal year 2025, via 10-K filed 2026-03-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$54.27M
Free cash flow margin
—
Liabilities / assets
9.0%
Equity / assets
91.0%
CapEx / revenue
—
Operating cash flow / net income
0.94×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$57.59M $117.18M $10.55M $106.63M
2024 — -$20.59M $77.51M $5.39M -$54.64M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-11
Financials filed via
Form 10-K
filed 2026-03-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92122
4370 LA JOLLA VILLAGE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies